CRISPR Therapeutics (CRSP) PT Raised to $52 at Baird
Tweet Send to a Friend
(Updated - May 9, 2024 6:27 AM EDT)
Baird analyst Jack Allen raised the price target on CRISPR Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Baird analyst Jack Allen raised the price target on CRISPR Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
